Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02126319 · ClinicalTrials.gov registry record · NA
Facilitating Participation in a Prostate Cancer Risk Assessment Program
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT02126319: Completed NA study, sponsored by Fox Chase Cancer Center.
NCT02126319 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02126319, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
The purpose of this study was to examine whether a cognitive-affective preparation was more beneficial, in general, and more specifically for certain subgroups, such as African-American men and individuals with high monitoring style.
Primary Outcome
Knowledge about Pca risk was measured using an eight item scale prepared for this study. It consisted of true/false items \[e.g., "An abnormal digital rectal examination (DRE) and/or prostate-specific antigen (PSA) could be the result of conditions other than prostate cancer"\]. Correct responses received a value of one, whereas false responses received a zero. Values ranged between zero and eight. Higher score means better knowledge of risk and issues.
Interventions
- BEHAVIORAL General Health Education
- BEHAVIORAL Cognitive Affective preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 1998-10 |
| Est. Completion | 2002-04 |
| Phase | NA |
What the finished NCT02126319 record still lists
NCT02126319 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which General Health Education is the first listed.
NCT02126319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02126319 about?
NCT02126319 is a clinical study titled "Facilitating Participation in a Prostate Cancer Risk Assessment Program". The purpose of this study was to examine whether a cognitive-affective preparation was more beneficial, in general, and more specifically for certain subgroups, such as African-American men and individuals with high monitoring style.
What is the current status of trial NCT02126319?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 1998-10. Estimated completion is 2002-04.
What interventions are being tested in trial NCT02126319?
The interventions under investigation include: General Health Education (BEHAVIORAL), Cognitive Affective preparation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02126319?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02126319's enrollment target sits among peer trials
128 744th of 2000 higher than 1,252 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia